Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor.
- 1 February 1991
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 83 (2) , 469-475
- https://doi.org/10.1161/01.cir.83.2.469
Abstract
The vascular effects of endothelin-1 (ET) in humans were investigated by brachial artery infusions of ET into 25 healthy volunteers. Forearm blood flow increased from a mean +/- SD value of 2.3 +/- 1.5 to 2.5 +/- 1.5 ml/min/100 ml forearm tissue (n = 25, p less than 0.05) in response to low dose (0.5 ng/min/100 ml forearm tissue) ET infusion and decreased to 1.78 +/- 1.3 and 1.1 +/- 0.9 ml/min/100 ml forearm tissue (p less than 0.001) during higher dosages (25 and 50 ng/min/100 ml forearm tissue). Sodium nitroprusside (0.6 micrograms/min/100 ml forearm tissue, n = 6), acetylcholine (16 micrograms/min/100 ml forearm tissue, n = 7), nifedipine (6 micrograms/min/100 ml forearm tissue, n = 6), and verapamil (80 micrograms/min/100 ml forearm tissue, n = 6) were infused alone and in combination with ET to evaluate the interactions between ET-induced vasoconstriction and stimulation of vascular muscle cyclic GMP levels by sodium nitroprusside, release of endothelium-derived relaxing factor by acetylcholine, and blockade of voltage-operated calcium channels by nifedipine and verapamil. Neither the vasodilator nor the vasoconstrictor response to ET was influenced by sodium nitroprusside or acetylcholine. In contrast, both calcium antagonists converted ET-induced vasoconstriction (e.g., delta forearm vascular resistance to ET 50 ng/min/100 ml forearm tissue, 151 +/- 100% and 164 +/- 92% in verapamil and nifedipine groups, respectively) to vasodilation (-35 +/- 12% and -21 +/- 16%, p less than 0.05). Our results demonstrate both ET-induced vasodilation (at low dosages) and vasoconstriction (at high dosages) in resistance vessels of normal humans. Blockade of voltage-operated calcium channels prevented ET-induced vasoconstriction and unmasked the vasodilator effect of high ET dosages. In human resistance vessels, blockade of voltage-operated Ca2+ channels but not cyclic GMP-dependent vasodilation may be an effective tool to inhibit ET-induced vasoconstriction.Keywords
This publication has 43 references indexed in Scilit:
- Different Mobilization of Calcium in Endothelin-1 -Induced Contractions in Human Arteries and Veins: Effects of Calcium AntagonistsJournal of Cardiovascular Pharmacology, 1990
- Endothelin-1 induces vasoconstriction through two functionally distinct pathways in porcine coronary artery: Contribution of phosphoinositide turnoverBiochemical and Biophysical Research Communications, 1989
- Presence of immunoreactive endothelin in human plasmaFEBS Letters, 1989
- Effects of Endothelin-1 and Endothelin-3 on Blood Pressure in Conscious Hypertensive RatsJournal of Cardiovascular Pharmacology, 1989
- Pharmacology of Endothelin-1 in Isolated VesselsJournal of Cardiovascular Pharmacology, 1989
- Molecular mechanism of action of the vasoconstrictor peptide endothelinBiochemical and Biophysical Research Communications, 1988
- Endothelin is a potent secretagogue for atrial natriuretic peptide in cultured rat atrial myocytesBiochemical and Biophysical Research Communications, 1988
- Cloning and sequence analysis of cDNA encoding the precursor of a human endothelium‐derived vasoconstrictor peptide, endothelin: Identity of human and porcine endothelinFEBS Letters, 1988
- Hemodynamic and reflex responses to acute and chronic antihypertensive therapy with the calcium entry blocker nifedipine.Hypertension, 1983
- Enhanced alpha-adrenoreceptor-mediated vasoconstriction in essential hypertension.Hypertension, 1981